superior to cortisone would be discovered. Since then, at least seven more cortisone-like steroids have been found useful clinically; these include hydrocortisone, 9-alpha-fluorohydrocortisone (Fludrocortisone), prednisone, prednisolone, a compound whose structure is 9-alpha-fluoro, delta 1-hydrocortisone, and the two most recent additions, namely triamcinolone and 6-methyl, delta I-hydrocortisone.
Each of these eight compounds has distinctive characteristics. Cortisone is the least costly to prepare synthetically; it is still useful in many cases and preferable in some. Hydrocortisone, appar- ently the major product of the normal human adrenal cortex, has proved to be superior to cortisone in local, especially intra-articular, administration. Fludrocortisone possesses a greatly enhanced antirheumatic effect (about ten times greater than that of cortisone, milligram for milligram); however, its effect on the retention of sodium and chloride and the excretion of potassium is even more enhanced. Thus, fludrocortisone is especially useful in the adrenal insufficiency of Addison's disease and when used in ointments for certain dermatological conditions, but the qualities that make it superior to cortisone or hydrocortisone in the management of Addison's disease interfere with its usefulness for rheumatic patients. Nevertheless, its production represented a distinct advance, because it demon-strated that chemists could alter the steroid molecule so as to prepare synthetic compounds with even more selective effects. This paved the way for the dissociation of one effect from another, so that one or more of these effects could be enhanced relatively.
The chemical structure of prednisone (delta 1-cortisone) and prednisolone (delta I-hydrocortisone) differs from that of cortisone and hydrocortisone, respectively, only in the possession of a double bond (hence the designation "delta") between the first and second carbon atoms in ring A of the molecule (Fig. 1, overleaf) . It is this slight change that invests these synthetic cortisone-like steroids with an increased antirheumatic potency and a decreased effect on the metabolism of electrolytes when compared, milligram for milligram, with cortisone and hydrocortisone. It was hoped that a similar alteration of the 9-alpha-fluorohydrocortisone molecule might lessen the pronounced effect of that compound on electrolytes and perhaps might even enhance its great antirheumatic effect. Such did not prove to be the case, however, and the aforementioned 9-alpha-fluoro, delta 1-hydrocortisone proved to be similar in effect to 9-alpha-fluorohydrocortisone (Thorn, Renold, Morse, Goldfien, and Reddy, 1955; Bunim, 1957) .
Triamcinolone has the chemical structure 16 alphahydroxy, 9-alpha-fluoro, delta 1-hydrocortisone. Its rheumatic potency appears to be approximately that of prednisone (Hellman, Zumoff, Schwartz, Gallagher, Berntsen, and Freyberg, 1957) . Medrol, which is the afore-mentioned 6-methyl, delta 1-hydrocortisone, also is said to have about the same anti-rheumatic potency as prednisone (Glenn, Stafford, Lyster, and Bowman, 1957) . Whether these two newest steroids will have additional practical therapeutic advantages remains to be determined by further clinical studies. 
ANNALS OF THE RHEUMATIC DISEASES

Present Study
We have studied the antirheumatic and other clinical effects of prednisone and prednisolone on many patients who had rheumatoid arthritis. In three such cases, we also made special studies concerning the metabolic effects of prednisone and in two of these three cases we compared these effects with those of cortisone or hydrocortisone.
The metabolic balances of sodium, chloride, potassium, total nitrogen, calcium, and inorganic phosphorus were studied by procedures and methods described previously (Sprague and others, 1950; Hench and others, 1950; Ward, Polley, Slocumb, Hench, Mason, Mattox, and Power, 1954; Salassa, Power, Ulrich, and Hayles, 1954 These results, together with those from numerous other patients whom we have studied clinically, confirm the findings of Bunim, Pechet, and Bollet (1955a) and of Boland (1955; 1956) , Bunim and others (1955b) , Dordick and Gluck (1955) , Bunim, Black, Bollet, and Pechet (1955) Fig. 3 and in subsequent comparable figures, daily intake is measured downward (but not blocked in) from the 0 line, and is represented by the distance from the 0 line to the bottom line of the column. The average daily excretion (faecal, hatched column; urinary, clear column) is charted upward from the bottom line. Each column represents a 6-day period. Each dot represents the daily balance calculated by subtracting from the daily intake the sum of the daily urinary excretion and one-sixth of the faecal excretion for that 6-day period. A negative balance is indicated when the top of the column or the dot is above the 0 line; a positive balance is indicated by a position below the 0 line. The approximately equivalent antirheumatic doses of prednisone (20 mg.) and hydrocortisone (80 mg.) in Case 1 produced about the same degree of undesired side-effects in that patient. Thus, prednisone was about four times as potent as hydrocortisone not only in antirheumatic activity but also in the production of undesired side-effects. (Boland, 1956 ). On the other hand, studies based on the initial information that triamcinolone was about twice as potent as prednisone in antirheumatic effect (Hellman and others, 1957) have already led to mistaken conclusions concerning its freedom from undesired sideeffects, since more recent data suggest that the ratio is more nearly 1: 1 (Hellman and others, 1957) . Effect on Electrolytes.-Prednisone caused an initial increase in excretion of sodium and chloride, whereas hydrocortisone in Case 1 and, to a lesser extent, cortisone in Case 2 led to retention of these electrolytes.
Only prednisone was given in Case 3. Thus, in these short-term studies, the effects of prednisone and those of cortisone or hydrocortisone on sodium and chloride tended to operate in opposite directions.
However, although there was a loss of sodium and chloride during the first 2 weeks or so of administration of prednisone, later during treatment these electrolytes tended to be approximately in balance.
Individual differences in the effect of prednisone on the sodium and chloride balances were notable, the excretion of _ these substances being increased most in 6-da% periods doses of less than 8 to 10 mg. per day generally produces little or no oedema or hypopotassaemia, even when administration is prolonged, but larger doses have produced these effects. Other observers also have reported oedema, retention of sodium, and loss of potassium during administration of prednisone. As many others have emphasized, the effect of prednisone (Thorn and others, 1955; Dordick and Gluck, 1955; Nelson, 1955) apparently result not from a primary disturbance of calcium metabolism but rather from a disturbance in protein metabolism and interference with formation of bone matrix (Clark, Bauer, Appleton, and Manning, 1956 (Dordick and Gluck, 1955; Bunim and others, 1955; Villa and others, 1955; Cohen and others, 1955) .
Effect on Blood Fats.-Administration of prednisone and cortisone or hydrocortisone may increase the blood fats (Bunim and others, 1955a; Dordick and Gluck, 1955; Bunim and others, 1955; Villa and others, 1955; Wang, Bossak, and Adlersberg, 1955; Adlersberg, Schaefer, and Drachman, 1950 prednisone and hydrocortisone produced rather similar increases in blood fats. Again, individual variation was evident, since the effects were less notable in Cases 2 and 3, even though the doses of steroids were greater.
Effect on Circulating Blood Cells.-Prednisone produced changes in circulating blood cells similar to those produced by cortisone or hydrocortisone, namely a tendency to an increase in haemoglobin and neutrophilic polymorphonuclear cells and a decrease in lymphocytes, eosinophils, and basophils (Thorn and others, 1955; Bunim and others, 1955a; Dordick and Gluck, 1955; Villa and others, 1955; Hollander, 1955; Cohen and others, 1955) .
Effect on Urinary Excretion of Steroids.-Prednisone decreased the urinary excretion of 17-ketosteroids and increased the urinary excretion of formaldehydogenic corticosteroids in these three patients. This decrease in 17-ketosteroids, also noted by others (Bunim and others, 1955a; Bunim and others, 1955; Villa and others, 1955) ed a decrease of no apparent significance in the basal metabolic rate, as has been noted previously during use of cortisone or hydrocortisone (Sprague and others, 1950) . Such decreases have been attributed to improvement in the rheumatoid arthritis as well as to more direct but less certainly defined effects on the metabolism of the thyroid gland and its hormone (Sprague and others, 1950; Thorn, Jenkins, Laidlaw, Goetz, Dingman, Arons, Streeten, and McCracken, 1954) . Prednisone did not alter the electroencephalograms or the electrocardiograms, although hydrocortisone-induced hypopotassaemia led to lowered T-waves in the electrocardiogram of one patient (Case 1).
Comments on Clinical Use of Prednisone and Prednisolone in Rheumatic Diseases, especially Rheumatoid Arthritis Prednisone and prednisolone, like their predecessors, cortisone and hydrocortisone, are useful antirheumatic steroids. Their lessened effect on electrolytes is especially advantageous for patients who have a tendency to retain fluid or lose potassium, or for patients who require comparatively large doses of an antirheumatic steroid, as in acute rheumatic fever or a severe flare of systemic lupus erythematosus. However, previously available steroids such as cortisone or hydrocortisone, as we used them (Ward, Polley, Slocumb, and Hench, 1953; Hench and Ward, 1954) , seldom caused serious or uncontrollable disorders in electrolytes when the doses employed for prolonged treatment of uncomplicated rheumatoid arthritis were small enough to avoid other manifestations of hypercortisonism. In respect to the production by overdosage of other undesirable effects, such as obesity, supraclavicular fat pads, hypertrichosis, acne, psychic changes, osteoporosis, peptic ulcers, striae, purpura, and hypertension, prednisone and prednisolone are generally similar to cortisone or hydrocortisone in equivalent antirheumatic doses.
The use of prednisone or prednisolone in rheumatoid arthritis requires the same general precautions as the use of cortisone or hydrocortisone (Ward and others, 1953; Hench and Ward, 1954 (3) The physician should recheck the patient at frequent intervals to evaluate his progress, to regulate dosage, and to note and care for any side-effects or impending complications (Hench and Ward, 1954) . In lieu of oedema as an early manifestation of hypercortisonism, the physician must watch for other signs, such as mental stimulation, increased appetite, gain in weight beyond the patient's predisease weight, slight facial hypertrichosis, minor degrees of facial rounding and supraclavicular fat pads, increase in blood pressure, and menstrual irregularities or increased menopausal symptoms.
(4) Doses should be measured individually to provide an optimal antirheumatic effect without hypercortisonism. Not only the total 24-hr dose, but also each 6-hr or 8-hr dose should be adjusted to fit each particular case. Individual requirements and tolerance for prednisone or prednisolone, like those for other antirheumatic steroids, may vary considerably. Hypercortisonism will develop in many instances during prolonged administration of prednisone or prednisolone if the doses shown in Table II are exceeded or, in some cases, even maintained. individual dosage schedules to provide optimal antirheumatic effects without hypercortisonism, special precautions at times of increased stress, and appropriate supportive and supplementary therapy. The synthesis of these new cortisone-like steroids, prednisone and prednisolone, like that of fludrocortisone, is of great importance in providing further evidence that the basic structure of cortisone can usefully be altered.
En clinique, la prednisone ou la prednisolone exigent les memes mesures de precaution que la cortisone ou l'hydrocortisone, c'est-a'-dire une selection soigneuse des malades, surveillance medicale etroite pendant le traitement, administration adapted aux besoins du malade individual, de maniere a obtenir un effet antirhumatismal optimum sans hypercortisonisme, soins speciaux en temps de tension augmentee et therapie supplementaire et de soutien appropriee.
La synthese des steroides genre cortisone, tels que la prednisone, la prednisolone et la fluorocortisone est importante car elle montre que la structure essentielle de la cortisone peut ere modifiee avantageusement.
La prednisona en la artritis reumatoide: efectos cinicos y metab6licos SUMARIO La prednisona (o la prednisolona), administrada a enfermos con artritis reumatoide, se parece a la cortisone o la hidrocortisona en su efecto antirreumatico, sobre el metabolism nitrogenado, hidrocarbonado y lipido, sobre la supresi6n de la funci6n suprarreno-corticopituitaria y en su influencia sobre los gl6bulos sanguineos y el metabolism basal.
Se notan, sin embargo, dos diferencias importantes:
(1) La prednisona, a peso igual, es al menos cuatro o cinco veces mias poderosa que la cortisone o la hidrocortisona en su acci6n antirreumiatica, asi como en sus efectos metab6licos estudiados, con excepci6n de los efectos sobre los electrolitos.
(2) El efecto de la prednisona es relativamente menor sobre el metabolism de los electrolitos; la retenci6n s6dica, clorurada y acuosa, asi como la excreci6n potisica son menores que con la cortisone o hidrocortisona en dosis antirreumaticas iguales.
En cinica, la prednisona o la prednisolona exigen la misma cautela que la cortisone o la hidrocortisona, quiere decir, una selecci6n cuidadosa de enfermos, vigilancia medica apropiada del tratamiento, administraci6n adaptada a las necesidades individuales para obtener un efecto antirreumatico 6ptimo sin hipercortisonismo, cuidados especiales en tiempo de tension aumentada y terapia suplemental y de soporte apropiada.
La sintesis de esteroides del tipo de cortisone, como la prednisona, la prednisolona y la fluorocortisona es importante, por demostrar que la estructura esencial de la cortisone se puede modificar provechosamente.
